28 results on '"Simeon-Aznar C"'
Search Results
2. POS1325 TREATMENT WITH NINTEDANIB IN SYSTEMIC SCLEROSIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE: SAFETY AND EFFECTIVENESS AFTER ONE YEAR IN A REAL-LIFE COHORT
3. OP0238 IMMUNOSUPPRESSION WITH TARGETED DMARDS REDUCES MORBIDITY AND MORTALITY IN PRE-CAPILLARY PULMONARY HYPERTENSION ASSOCIATED WITH SYSTEMIC SCLEROSIS: A EUSTAR ANALYSIS
4. AB0832 CHRONIC INTESTINAL PSEUDO-OBSTRUCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS
5. POS1312 PREVALENCE OF GASTROINTESTINAL SYMPTOMS AND OBJECTIVE GASTROINTESTINAL DYSMOTILITY IN PATIENTS WITH SYSTEMIC SCLEROSIS
6. POS0121 COMPARISON OF FOUR RISK STRATIFICATION MODELS FOR PREDICTION OF MORTALITY IN SSc-PAH IN THE EUSTAR COHORT
7. AB0882 ADVANCED GLYCATION END PRODUCTS IN SYSTEMIC SCLEROSIS
8. POS1243 THE ROLE OF TAPSE/SPAP RATIO IN PREDICTING PULMONARY HYPERTENSION AND MORTALITY IN THE SYSTEMIC SCLEROSIS EUSTAR COHORT
9. POS1332 ANTI-NUCLEAR VALOSIN-CONTAINING PROTEIN-LIKE AUTOANTIBODIES ARE ASSOCIATED WITH A NEW CLINICAL PHENOTYPE IN SYSTEMIC SCLEROSIS PATIENTS: LIMITED CUTANEOUS SUBSET WITH RECALCITRANT CALCINOSIS AND HIGHER RISK OF CANCER
10. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
11. Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension (vol 12, 5289, 2022)
12. ADVANCED GLYCATION END PRODUCTS IN SYSTEMIC SCLEROSIS.
13. CHRONIC INTESTINAL PSEUDO-OBSTRUCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS.
14. SYSTEMIC SCLEROSIS ASSOCIATED ANTIBODIES POSITIVITY IN SYSTEMIC SCLEROSIS PATIENTS: SINGLE VS. COMBINATION.
15. AB0891 Long-Term Cumulative Organ Damage Assessment in A Cohort of Patients with Juvenile Dermatomyositis: Table 1
16. Tratamiento del fenómeno de Raynaud
17. THU0480 AA-Amyloidosis as Diagnostic Clue of a Family with Atypical Cryopirin Associated Periodic Syndrome with Muckle-Wells Syndrome Phenotype
18. Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis
19. Intravenous Cyclophosphamide Pulse Therapy in the Treatment of Systemic Sclerosis-Related Interstitial Lung Disease: A Long Term Study
20. Anti-PDGFR- antibodies measured by non-bioactivity assays are not specific for systemic sclerosis
21. Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients
22. Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes
23. Systemic sclerosis, breast cancer and calcium channel blockers: A new player on the scene?
24. Thrombotic thrombocytopenic purpura preceding systemic lupus erythematosus.
25. TRANSVERSE MYELITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: TWO CASES WITH MAGNETIC RESONANCE IMAGING
26. TRANSVERSE MYELITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: TWO CASES WITH MAGNETIC RESONANCE IMAGING.
27. Pleural irregularity, a new ultrasound sign for the study of interstitial lung disease in systemic sclerosis and antisynthetase syndrome
28. Fulminant soft tissue infection by Salmonella enteritidis in SLE.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.